Clinical Trials for Boundless Bio

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Boundless Bio

Clinical Trials (1)

NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
PHASE1Recruiting
127 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2027
12 conditions1 sponsor17 locations